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OBJECTIVES Our objective was to define the outcomes of patients with cardiogenic shock (CS) due to
severe mitral regurgitation (MR) complicating acute myocardial infarction (AMI).
BACKGROUND Methods for early identification and optimal treatment of such patients have not been
defined.
METHODS The SHOCK Trial Registry enrolled 1,190 patients with CS complicating AMI. We
compared 1) the cohort with severe mitral regurgitation (MR, n 5 98) to the cohort with
predominant left ventricular failure (LVF, n 5 879), and 2) the MR patients who underwent
valve surgery (n 5 43) to those who did not (n 5 51).
RESULTS Shock developed early after MI in both the MR (median 12.8 h) and LVF (median 6.2 h)
cohorts. The MR patients were more often female (52% vs. 37%, p 5 0.004) and less likely
to have ST elevation at shock diagnosis (41% vs. 63%, p , 0.001). The MR index MI was
more frequently inferior (55% vs. 44%, p 5 0.039) or posterior (32% vs. 17%, p 5 0.002) than
that of LVF and much less frequently anterior (34% vs. 59%, p , 0.001). Despite having
higher mean LVEF (0.37 vs. 0.30, p 5 0.001) the MR cohort had similar in-hospital
mortality (55% vs. 61%, p 5 0.277). The majority of MR patients did not undergo mitral
valve surgery. Those undergoing surgery exhibited higher mean LVEF than those not
undergoing surgery; nevertheless, 39% died in hospital.
CONCLUSIONS The data highlight opportunities for early identification and intervention to potentially
decrease the devastating mortality and morbidity of severe post-myocardial infarction MR.
(J Am Coll Cardiol 2000;36:1104–9) © 2000 by the American College of Cardiology
Severe mitral regurgitation (MR) complicating acute myo-
cardial infarction (AMI) is an important cause of hemody-
namic instability and cardiogenic shock (CS). Nonrandom-
ized series that have reported favorable outcomes after early
mitral valve surgery have led to recommendations that early
surgery is appropriate in such patients (1–10). However,
these series are subject to powerful selection and publication
biases. In the absence of randomized trials, reports charac-
terizing large unselected cohorts of hemodynamically unsta-
ble patients with severe MR complicating AMI are needed
to provide broader context, assist clinical decision making,
and highlight areas for prospective investigation.
A pre-trial SHould we use emergently revascularize
Occluded Coronaries in cardiogenic shocK? (SHOCK)
Trial Registry prospectively collected data on 251 patients
with CS at 19 centers between January 1992 and April 1993
(11). In that preliminary registry 19 (7.6%) patients with CS
had acute severe MR or rupture of the ventricular septum,
accounting for shock. It is interesting that only 8 of 19
patients had cardiac catheterization and only 4 of 19 had
cardiac surgery. Mortality was 100% in the surgical group
and 80% in those who did not undergo surgery. Thus,
despite the previous favorable reports promoting surgical
treatment of mechanical CS, the SHOCK Trial Registry
indicated that a significant proportion of patients with
mechanical causes of CS did not undergo surgery and that
surgical mortality was high. The SHOCK Trial Registry
provides an opportunity to re-examine these findings in a
much larger unselected population. There were two aims of
the SHOCK Trial Registry analysis: 1) to describe the
cohort in the Registry with acute severe MR and to compare
it with the cohort with predominant left ventricular (LV)
failure not accompanied by severe MR or other mechanical
complications; and 2) to compare the characteristics and
outcome of surgically and nonsurgically-treated severe MR
patients.
METHODS
Study design. Patients with suspected CS complicating
AMI, whether meeting strict trial criteria for CS or not,
were prospectively registered. Thirty-six enrolling centers
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were initiated in a staggered fashion, and the first patient
was enrolled in April 1993. A local discharge diagnosis of
AMI and CS (DRG’s 410 and 785.51) constituted criteria
for being registered. Acute severe MR, ventricular septal
rupture, isolated right ventricular failure, cardiac tamponade
or rupture, prior severe valvular heart disease and iatrogenic
shock constituted etiologies of shock other than predomi-
nant LV failure and were SHOCK Trial clinical exclusion
criteria. Importantly, patients with acute severe MR without
CS were not consistently registered, because a diagnosis of
suspected CS was required.
Patients. The SHOCK Trial Registry consisted of 1,190
patients. In order to compare well-categorized, distinct
groups, five patients with shock due to predominant LV
failure with moderate MR and 208 patients who had shock
that was not caused by either MR or predominant LV
failure, were excluded. The data set for this article therefore
consists of 977 patients—98 patients who had CS with
acute severe MR and a comparison group of 879 patients
with predominant LV failure. The diagnosis of acute severe
MR was made at the local SHOCK enrolling center.
Data collection. Data were abstracted from the medical
record by local SHOCK study coordinators who were
centrally trained to complete standardized study report
forms. Patient characteristics, MI characteristics, hemody-
namics, utilization of medications and procedures, and vital
status at hospital discharge were recorded. Cardiac cathe-
terization and angiography reports were sent to the Clinical
Coordinating Center for abstraction of information and
completion of a standardized form. The following variables
were recorded only on revised data collection forms and are
therefore available from only two-thirds of the patient
sample: LV ejection fraction, inotrope usage, the presence
of ST segment elevation at shock, pulmonary edema, and
the presence of rales.
Definitions. Electrocardiogram (ECG) locations were de-
fined according to the Global Utilization of Streptokinase
and tPA for Occluded Coronary Arteries (GUSTO) 1
classification scheme; (i.e., V1 2 V4 Anterior; II, III, AVF
Inferior; V5 2 V6 Apical; I, AVL Lateral; and V1 2 V2
Posterior)(12).
Statistical methods. Groups were compared using the
Fisher exact test for categorical variables, the Wilcoxon
rank-sum test for ordinal and non-normally distributed
continuous variables and the Student t-test for normally
distributed continuous variables. Covariate-adjusted in-
hospital mortality by group was analyzed using logistic
regression. In order to determine if group status was an
independent predictor of mortality, a multivariate model
was constructed by including all baseline patient character-
istic variables with a univariate p value for group comparison
of #0.20. All variables with a final p value of #0.05 were
retained in the model. All analyses were conducted using the
Statistical Analysis System (SAS, v. 6.12, SAS Institute,
Inc., Cary, North Carolina).
RESULTS
Baseline characteristics. The MR (n 5 98) and LV failure
(n 5 879) groups had similar pre-existing cardiovascular
conditions and major co-morbidities; however, a larger
proportion of MR patients were female (52% vs. 37%, p 5
0.004) and were admitted to the tertiary SHOCK Trial
center via transfer (65% vs. 42%, p , 0.001) (Table 1). The
ECG characteristics are described in Table 2. Both the
presence of ST elevation at the time of shock diagnosis and
the presence of ST elevation in at least two leads were less
frequent in the MR cohort (41% vs. 63%, p , 0.001; 47%
vs. 73%, p , 0.001). Among those with an identifiable
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
CS 5 cardiogenic shock
CABG 5 coronary artery bypass graft surgery
ECG 5 electrocardiogram, electrocardiographic
IABP 5 intra-aortic balloon pump
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PTCA 5 percutaneous transluminal coronary
angioplasty
SHOCK 5 SHould we emergently revascularize
Occluded Coronaries in cardiogenic shocK?
Table 1. Baseline Characteristics of Patients with CS Due to Severe MR Versus LV Failure
Severe MR Group
(n 5 98)
LVF Group
(n 5 879) p Value
Age (yrs) 70.6 (64.4, 77.0) 70.1 (61.0, 77.1) 0.384
Female gender 52% 37% 0.004
White, non-Hispanic 79% 84% 0.255
History of hypertension 58% 52% 0.236
Diabetes 33% 33% 0.909
History of renal insufficiency 11% 11% 0.859
Congestive heart failure 24% 20% 0.414
History of infarction 34% 40% 0.225
History of bypass surgery 10% 10% 1.00
History of angioplasty 5% 7% 0.826
Admit by transfer 65% 42% ,0.001
Data presented are median (25th, 75th percentiles) or percentages.
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index MI location by ECG, MR patients had a greater
prevalence of inferior MI (55% vs. 44%, p 5 0.039) and
posterior MI (32% vs. 17%, p 5 0.002) and a correspond-
ingly lower prevalence of anterior MI (34% vs. 59%, p ,
0.001). In those undergoing coronary angiography, the
identity of the infarct artery was consistent with these
observations.
Clinical and hemodynamic variables. Patients with MR
had later shock (median 12.8 vs. 6.2 h post-MI, p , 0.001)
(Table 2). Consistent with the known pathophysiology of
severe MR, the MR cohort had higher median LV ejection
fraction (0.37 [0.25, 0.48] n 5 58 vs. 0.30 [0.20, 0.40] n 5
335, p 5 0.001) yet more often had clinical and radio-
graphic evidence of pulmonary edema.
Interventions. Patients with MR were significantly more
likely to undergo all interventions except percutaneous
transluminal coronary angioplasty (PTCA) (Tables 3 and
4). Median time intervals from the onset of shock to right
heart catheterization (3.7 h vs. 2.1 h, p 5 0.030), left heart
catheterization (5.8 h vs. 2.6 h, p 5 0.009), and intra-aortic
balloon pump (IABP) (5.0 h vs. 3.1 h, p 5 0.036), while
relatively short in both groups, were longer in the MR
group. The median times from shock to bypass surgery were
similar in the MR (16.6 h [5.1, 55.3], n 5 36 and the LV
failure groups (29.2 h [3.9, 115.0], n 5 128), p 5 0.397.
Outcomes. Crude (unadjusted) in-hospital mortality was
similar for the two groups (MR vs. LV failure odds ratio
[OR] 0.79; 55% for MR and 61% for LV failure, p 5 0.277)
and did not differ significantly after adjustment for patient
outcome-related differences between the two groups—
namely, transfer status, prior MI, and posterior MI (MR vs.
LV failure OR 0.97, 95% confidence interval [CI] 0.60 to
1.56, p 5 0.900). Pulmonary edema was not included as an
adjustment factor, because it was considered to be a conse-
quence of MR. Patients with MR had a longer median
length of stay (10.7 [2.6, 20.6] days vs. 6.1 [1, 15.1] days
following shock, p 5 0.002). Among the survivors, 44
patients with MR were discharged after a median of 20.8
[12.3, 37.8] days, compared with 15.4 [10.1, 24.9] days for
343 LV failure patients p 5 0.005.
Surgical results. Among the 98 patients with MR, data
indicating whether or not valve surgery was performed were
available for 94. Almost half (46%) underwent valve replace-
ment (n 5 37) or valve repair (n 5 6). Six patients had
mitral valve surgery without coronary artery bypass graft
surgery (CABG), and 37 with CABG.
The characteristics of the patients with MR who under-
went mitral valve surgery and those without mitral valve
Table 2. Electrocardiographic, Clinical, Infarct, and Hemodynamic Characteristics of Patients
With CS Due to Severe MR Versus LV Failure. Hemodynamics Reported Are Those Closest to
Shock, Which Were Often Recorded While the Patient Was on Support
Severe MR Group
(n 5 98)
LV Failure Group
(n 5 879) p Value
Location of index infarction*
Anterior 34% 59% ,0.001
Inferior 55% 44% 0.039
Posterior 32% 17% 0.002
Lateral 32% 32% 1.000
Apical 11% 10% 0.704
Multiple infarct locations 52% 48% 0.570
ST-segment elevation at shock 41% 63% ,0.001
New left bundle branch block 19% 7% 0.378
Time from MI onset to shock (h) 12.8 (2.4, 36.3) 6.2 (1.7, 20.1) ,0.001
Highest creatine kinase (U/L) 1291 (603, 3,235) 1931 (630, 4,060) 0.075
Highest creatine kinase/ULN 7.8 (3.4, 14.4) 8.9 (2.9, 19.4) 0.241
Heart rate (beats/min) 98 (82, 110) 95.0 (79, 114) 0.454
Pulmonary edema on X-ray 81% 58% ,0.001
PCWP (mm Hg)† 21.5 (17, 28) 23.0 (18, 29) 0.259
Cardiac index (L/min/m2)† 1.9 (1.6, 2.4) 1.9 (1.5, 2.4) 0.727
Left ventricular ejection fraction (%)‡ 36.5 (25, 48) 30.0 (20, 40) ,0.001
Data presented are median (25th, 75th percentiles) or percentages. beats/min 5 beats per minute; MI 5 myocardial infarction;
PCWP 5 pulmonary capillary wedge pressure; ULN 5 upper limit of normal.
*MI location by ECG unknown in 13 MR and 92 LV failure patients. †RHC data available for 85% of MR and 64% of LV
failure patients. ‡LV ejection fraction was available in 58 MR and 335 LV failure patients.
Table 3. Treatment and Outcomes of Patients With CS Due to
Severe MR Versus LV Failure
Severe MR
Group
(n 5 98)
LV Failure
Group
(n 5 879) p Value
Thrombolytics administered 26% 34% 0.090
Mechanical ventilation 93% 75% ,0.001
Inotropic agents 88% 71% 0.002
Right heart catheterization 85% 64% ,0.001
Intra-aortic balloon pump 68% 52% 0.003
Coronary angiography 76% 61% 0.006
Angioplasty attempted 16% 33% 0.001
Angioplasty of IRA attempted 7% 20% 0.014
Repeat angioplasty attempted 1% 4% 0.009
Bypass surgery 43% 15% ,0.001
Angioplasty or bypass surgery 53% 46% 0.166
Transfusion 64% 39% ,0.001
In-hospital mortality 55% 61% 0.277
IRA 5 infarct-related artery.
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surgery were similar. Patients selected for surgery had lower
median highest creatine kinase (932 [516, 1,875] vs. 1,659
[738, 3319], p 5 0.030), and much higher in-hospital LV
ejection fraction (40% [35, 52], n 5 30 vs. 29% [24, 39],
n 5 28, p 5 0.004) than those selected for nonsurgical care
(Table 5). Intra-aortic balloon pump support was used in
almost all the surgical patients but in less than half of the
nonsurgical patients (Table 5). As expected, coincident
revascularization with CABG was much more common in
the surgical group; 4 of the 51 patients not undergoing valve
surgery underwent CABG. Unadjusted mortality in those
who underwent valve surgery was lower than in those who
did not (40% vs. 71%; OR 5 0.27, 95% CI 5 0.12 to 0.64,
p 5 0.003). Of the few patient factors distinguishing the
surgical and nonsurgical groups, only gender was even
marginally related to mortality (better survival for men), and
the adjusted odds ratio for death for surgical versus nonsur-
gical MR patients remained significant (OR 0.30, 95% CI
0.13 to 0.73, p 5 0.008).
The primary reasons for not undertaking mitral valve
surgery were 1) that the patient could not be stabilized or
died awaiting surgery (half of patients) and 2) the presence
of co-morbidities related to current illness or secondary to
shock (one-third of patients).
DISCUSSION
The development of severe MR complicating AMI and
leading to CS is widely recognized to be a medical catas-
trophe portending very poor prognosis. These data from the
SHOCK Trial Registry will do little to alter that opinion.
However, this observational study of a large and minimally
Table 4. Timing of Events in Patients With Severe MR Versus LV Failure. All Times Are in
Hours Unless Otherwise Noted
Timing
Severe MR Group
(n 5 98)
LV Failure Group
(n 5 879) p Value
Infarct to right-heart catheterization
(n 5 63, 599)
20.3 (7.0, 46.8) 12.6 (4.9, 30.9) 0.060
Shock to right-heart catheterization
(n 5 76, 250)
3.7 (0.7, 8.2) 2.1 (0.0, 5.8) 0.030
Shock to left-heart catheterization
(n 5 64, 499)
5.8 (2.1, 17.1) 2.6 (0.5, 9.5) 0.009
Shock to IABP (n 5 58, 434) 5.0 (2.1, 9.8) 3.1 (1.2, 8.0) 0.036
Shock to bypass surgery (n 5 36, 128) 16.6 (5.1, 55.3) 29.2 (3.9, 115.0) 0.397
Bypass surgery ,24 h after angioplasty
(n 5 16, 291)*
31% 4% 0.001
Shock to discharge (days) 10.7 (2.6, 20.6) 6.1 (1.0, 15.1) 0.002
Data presented are median (25th, 75th percentiles) or percentages. IABP 5 intra-aortic balloon pump.
*Denominator is all angioplasty patients.
Table 5. Infarct Size, Hemodynamics, Treatment and In-hospital Mortality by Valve-surgery
Status of Patients With Severe Complicating Acute MI. Hemodynamics Reported Are Those
Closest to Shock, Which Were Often Recorded While the Patient Was on Support
Valve Surgery
(n 5 43)
No Valve Surgery
(n 5 51) p Value
Highest creatinine kinase (U/L) 932 (516, 1875) 1659 (738, 3319) 0.030
Highest creatinine kinase/ULN 4.9 (3.1, 9.5) 11.1 (3.9, 16.6) 0.022
Heart rate (beats/min) 96 (82, 106) 98 (81, 113) 0.714
Pulmonary edema on X-ray 81% 81% 1.000
PCWP (mm Hg) 21 (17, 27) 23 (18, 28) 0.463
Cardiac index (L/min/m2) 1.9 (1.5, 2.4) 1.9 (1.6, 2.4) 0.994
Left ventricular ejection fraction (%) 40 (35, 52) 29 (24, 39) 0.004
Thrombolytics administered 26% 26% 1.000
Mechanical ventilation 98% 88% 0.120
Inotropic agents 97% 79% 0.029
Right heart catheterization 93% 77% 0.049
Left-heart catheterization 93% 61% , 0.001
Intra-aortic balloon pump 98% 43% , 0.001
Angioplasty attempted 16% 18% 1.000
Bypass surgery 86% 8% ,0.001
Angioplasty or bypass surgery 88% 26% , 0.001
Transfusion 93% 40% , 0.001
In-hospital mortality 40% 71% 0.003
Shock onset to discharge (d) 16.0 (6.0, 34.1) 6.7 (1.1, 13.4) , 0.001
Data presented are median (25th, 75th percentiles) or percentages. beats/min 5 beats per minute; PCWP 5 pulmonary capillary
wedge pressure; ULN 5 upper limit of normal.
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selected cohort of patients with CS accompanied by acute
severe MR provides insights not available in smaller or more
selected series. The contemporaneous cohort of patients
with predominant LV failure provides unique opportunities
for comparison. Many baseline characteristics of the MR
and LV failure groups were similar, reflecting a common
risk profile for their underlying coronary artery disease and
acute coronary syndrome. However, several potentially im-
portant differences emerged.
First, the distribution of electrocardiographic and angio-
graphic infarct zones supports previous clinical and patho-
logical work indicating that severe MR most often reflects
necrosis of the posteromedial papillary muscle (13–15).
Conversely however, anterior infarction was present in
one-third of our population. Clearly, the presence of ante-
rior infarction should not dissuade clinicians from consid-
ering acute MR when other clinical signs and symptoms
suggest it. Furthermore, less than half the MR cohort
displayed clinically recognized ST-segment elevation or new
Q waves. It is a sobering observation that half or more of the
instances of acute severe MR and shock develop in the
absence of these markers of extensive necrosis. Nevertheless,
despite the absence of ST elevation, complete vessel occlu-
sion was likely present in many patients, posterior chest
leads were not commonly used at the time of the SHOCK
Trial Registry, and there were a substantial number of
circumflex infarcts. Along with findings regarding the lim-
ited enzymatic elevations that characterized our MR cohort
(median CPK elevation , 5 fold upper limit normal), these
observations indicate that acute severe MR with shock is
often a consequence of infarction or dysfunction of limited
but exquisitely important myocardium.
The interesting observation of a higher prevalence of
women with acute severe MR in our cohort, compared with
patients having predominant LV failure, appears to confirm
a similar observation by Tcheng et al. (5). There are further
corresponding observations of an increased prevalence of
women with acute severe MR causing shock, compared with
other causes of shock, in the pre-SHOCK Trial Registry by
Hochman et al. (11) and the main SHOCK Trial Registry
(16). The Tcheng report predominantly included patients
without shock. The effect, if true, therefore appears distinct
from hemodynamic issues and implies gender-related fac-
tors specific to the mitral mechanism itself. Differences in
patterns of vascular supply, collateralization, connective
tissue, or in the clinical presentation and detection of MR
are all possible explanations and warrant further study. The
higher proportion of MR patients admitted via transfer
likely reflects a belief among referring physicians that
emergency surgery for acute severe MR is life-saving and
indicated. Shock apparently due to a reversible mechanical
cardiac defect such as acute MR seems intrinsically suited to
emergent surgery. Until recently, it has been a less-than-
intuitive concept that shock from LV failure, even when
myocardial necrosis is well established, would benefit from
emergency revascularization. This clinical predisposition to
obtain emergency surgery for acute severe MR has been
given additional credence from recommendations arising
from nonrandomized case series.
Although the LV ejection fraction was higher in the MR
group than in the LV failure group, it is important to
recognize that the median LV ejection fraction of 37%
represents marked impairment of LV systolic performance
in the presence of MR. The higher ejection fraction reflects
both a smaller infarct size and the reduced impedance to LV
ejection contributed by ejection into the left atrium. The
higher prevalence of pulmonary edema in the MR patients
might be expected, considering the sudden regurgitant
volume into the left atrium and pulmonary veins seen with
acute severe MR.
Comparison of surgical versus nonsurgical treatment of
severe MR. Because reports of nonrandomized studies
suggest that surgery is desirable when shock results from
mechanical disruption of the mitral apparatus (1–5), valve
surgery is the treatment of choice in many centers. Our data,
however, reveal the degree to which selection bias may have
influenced the outcomes in such series, including our own.
In this multicenter database involving numerous cardiolo-
gists and cardiovascular surgeons, we observed systematic
surgical selection of patients with better LV function and
smaller index infarctions. The effects of such selection on
outcome was no doubt amplified 1) by the deferment or
death of patients considered for surgery who were deemed
too ill to operate on immediately and 2) by the exclusion of
a cohort of gravely ill MR patients who may have died
during or prior to transport, and were therefore never
registered. Finally, the relative contribution of revascular-
ization versus repair of the mitral valve is unclear.
Even among registered patients, fewer than half under-
went surgery. A potential criticism of the low surgical
treatment rate is that clinicians caring for these patients
were unduly conservative when selecting patients for mitral
valve surgery. This criticism should be tempered by the 40%
hospital mortality rate of those who received mitral valve
surgery (a mortality rate comparable to that reported in
other series), as well as by the multicenter nature of the
Registry. Perhaps, however, surgery should have been per-
formed more promptly in the patients who were considered
too ill or who died while waiting for surgery, who comprised
over one-third of the MR cohort. In conjunction with
approximately 10% of MR patients in the SHOCK Trial
Registry who were treated medically because of co-
morbidity arising secondary to CS, these observations high-
light the need for very early recognition, support and
decision making in any future prospective evaluation of
emergency surgery for this condition. Some patients in the
registry received PTCA rather than mitral valve surgery
with CABG. Although a favorable response of acute severe
MR to percutaneous transluminal coronary angioplasty
(PTCA) has previously been reported (17–20), Tcheng
observed that acute reperfusion with thrombolysis or angio-
plasty did not usually reverse MR in a group of 50 patients
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with moderately severe or severe MR receiving treatment
for AMI (5). In that series, the early and late mortality was
higher in the PTCA group than in those treated medically
or with surgery. Nine patients with severe MR in the
present registry were treated with PTCA alone, six of whom
subsequently died. An additional five patients underwent
CABG within 24 h of PTCA, and three of these patients
died.
Physicians should consider clinically undetected MR in
CS—particularly in women and those with non-ST eleva-
tion MI, inferoposterior MI and pulmonary edema. Despite
the selection of less than half of severe MR patients for
surgery, in-hospital surgical mortality was extremely high at
40%. Clearly, efforts are needed to enhance earlier recogni-
tion of severe MR complicating AMI, because earlier
surgery (before shock develops) may lead to improved
prognosis.
Reprint requests and correspondence: Dr. C.R. Thompson,
Director, Cardiology Clinical Research, St. Paul’s Hospital, Room
5134-1081 Burrard Street, Vancouver, B.C., Canada V6Z 1Y6.
E-mail: cthompson@Providencehealth.bc.ca.
REFERENCES
1. Nishimura RA, Schaff HV, Gersh BJ, Holmes DR Jr, Tajik AJ. Early
repair of mechanical complications after acute myocardial infarction.
JAMA 1986;256(1):47–50.
2. Bolooki H. Surgical treatment of complications of acute myocardial
infarction. JAMA 1990;263(9):1237–40.
3. Dresdale AR, Paone G. Surgical treatment of acute myocardial
infarction. Henry Ford Hosp Med J 1991;39(3-4):245–50.
4. Cercek B, Shah PK. Complicated acute myocardial infarction. Heart
failure, shock, mechanical complications. Cardiol Clin 1991;9(4):569–
93.
5. Tcheng JE, Jackman JD Jr, Nelson CL, et al. Outcome of patients
sustaining acute ischemic mitral regurgitation during myocardial in-
farction. Ann Intern Med 1992;117(1):18–24.
6. Bolooki H. Emergency cardiac procedures in patients in cardiogenic
shock due to complications of coronary artery disease. Circulation
1989;79:I137–48.
7. Fox AC, Glassman E, Isom OW. Surgically remediable complications
of myocardial infarction. Prog Cardiovasc Dis 1979;21(6):461–84.
8. Kouchoukos NT. Surgical treatment of acute complications of myo-
cardial infarction. Cardiovasc Clin 1981;11(3):141–9.
9. Defraigne JO, Lavigne JP, Remy D, Dekoster G, Limet R. [Mitral
valve replacement in post-infarction rupture of the papillary muscle.
Apropos of 13 cases surgically treated during the acute phase of
infarction]. Arch Mal Coeur Vaiss 1990;83(3):377–82.
10. Yamanishi H, Izumoto H, Kitahara H, Kamata J, Tasai K, Kawazoe
K. Clinical experiences of surgical repair for mitral regurgitation
secondary to papillary muscle rupture complicating acute myocardial
infarction. Ann Thorac Cardiovasc Surg 1998;4(2):83–6.
11. Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of
cardiogenic shock and effect of early revascularization on mortality.
Results of an International Registry. SHOCK Registry Investigators.
Circulation 1995;91(3):873-81.
12. The GUSTO investigators. An international randomized trial com-
paring four thrombolytic strategies for acute myocardial infarction.
N Engl J Med 1993;329(10):673–82.
13. Coma-Canella I, Gamallo C, Onsurbe PM, Jadraque LM. Anatomic
findings in acute papillary muscle necrosis. Am Heart J 1989;118(6):
1188–92.
14. Sharma SK, Seckler J, Israel DH, Borrico S, Ambrose JA. Clinical,
angiographic and anatomic findings in acute severe ischemic mitral
regurgitation. Am J Cardiol 1992;70(3):277–80.
15. Calvo FE, Figueras J, Cortadellas J, Soler-Soler J. Severe mitral
regurgitation complicating acute myocardial infarction. Clinical and
angiographic differences between patients with and without papillary
muscle rupture. Eur Heart J 1997;18(10):1606–10.
16. Hochman JS, Buller CE, Sleeper LA, et al., for the SHOCK
Investigators. Cardiogenic shock complicating acute myocardial infarc-
tion—etiologies, management and outcome: a report from the
SHOCK Trial Registry. J Am Coll Cardiol 2000;36:1063–70.
17. Heuser RR, Maddoux GL, Goss JE, Ramo BW, Raff GL, Shadoff N.
Coronary angioplasty for acute mitral regurgitation due to myocardial
infarction. A nonsurgical treatment preserving mitral valve integrity.
Ann Intern Med 1987;107(6):852–5.
18. Shawl FA, Forman MB, Punja S, Goldbaum TS. Emergent coronary
angioplasty in the treatment of acute ischemic mitral regurgitation:
long-term results in five cases. J Am Coll Cardiol 1989;14(4):986–91.
19. Le Feuvre C, Metzger JP, Lachurie ML, Georges JL, Baubion N,
Vacheron A. Treatment of severe mitral regurgitation caused by
ischemic papillary muscle dysfunction: indications for coronary angio-
plasty. Am Heart J 1992;123:860–5.
20. Karim MA, Hailu A, Deligonul U. Instantaneous resolution of
ischemic mitral regurgitation and pulmonary hypertension by angio-
plasty. Int J Cardiol 1994;47(2):183–6.
1109JACC Vol. 36, No. 3, Suppl A Thompson et al.
September 2000:1104–9 MR and CS in MI
